Research Paper Volume 15, Issue 16 pp 8155—8184
Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity
Figure 10. The expression of various cytokines when RP2 is highly expressed in LGG and GBM. (A) Immunoinhibitor. (B) MHC molecule. (C) Immunostimulator. (D) Lymphocyte. (E, F) RP2 was associated with the expression of TGF-β and IL-10. (G, H) RP2 was positively correlated with TGF-β and IL-10 mRNA expression.